MHRA Approves Zynyz for Advanced Anal Cancer
The UK Medicines and Healthcare products Regulatory Agency approved retifanlimab (Zynyz) for treatment of advanced anal cancer.
The UK Medicines and Healthcare products Regulatory Agency approved retifanlimab (Zynyz) for treatment of advanced anal cancer.